Dual Task Gait Performance in Pediatric Oncology Patients
NCT ID: NCT04784026
Last Updated: 2021-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2021-03-01
2023-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Most studies on children who survive cancer show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, gait and cognitive skills.
Therefore, dual task gait performance, in which cognitive and motor tasks are performed simultaneously, may be affected in pediatric oncology patients. The aim of this study is to compare gait performance in single and dual task conditions in pediatric oncology patients with healthy controls.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Dual-Task Training on Pediatric Oncology Patients
NCT05118464
Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment
NCT02216604
The Effect of Technology-Based Cognitive and Artistic Therapeutic Activities on the Mental Status of Children With Cancer
NCT05807308
HopeMove App in Pediatric Cancer Patients
NCT07274358
The Effect of Walking Intervention on Sleep Related Symptom Distress in Pediatric Oncology Patients
NCT01742325
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Most studies on children who survive cancer show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, gait and cognitive skills. According to the study of Beulertz et al. (2016), active ankle dorsiflexion limitation, gait disturbances and decrease in walking efficiency were observed in all pediatric oncology patients, which have an important role in walking, not limited to children with bone tumors and central nervous system tumors.Intensive chemotherapy (eg methotrexate) and the use of radiation are thought to cause damage to cortical and subcortical white matter, resulting in late effects. Symptoms consistent with attention deficit disorder and mental processing speed, working memory, executive function and memory deficits put cancer survivors at an intellectual and academic disadvantage.
Therefore, dual task gait performance, in which cognitive and motor tasks are performed simultaneously, may be affected in pediatric oncology patients. The aim of this study is to compare gait performance in single and dual task conditions in pediatric oncology patients with healthy controls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Control Group
Healthy children who come to Afyonkarahisar Ege Youth and Sports Club Association for the purpose of sports, newly registered and between the ages of 6-18 will constitute the control group of the study.
Gait assessment (single)
The single walk will be evaluated with a 10-meter walking test and a G-Walk portable device.
Dual task gait assessment (motor+motor)
The dual task gait, 10-meter walking test and a motor (carrying a full water glass) will be combined with the task and evaluated with the G-Walk portable device.
Dual tak gait assessment (motor+cognitive)
The dual task gait will be combined with a 10-meter walking test and a cognitive (1-back test) task and evaluated with the G-Walk portable device.
Case Group
The sample of the study will be inpatient and outpatient pediatric patients between the ages of 6-18 who have been diagnosed with cancer in the Pediatric Hematology-Oncology Clinics of Afyonkarahisar Health Sciences University Health Application and Research Center Department of Pediatrics.
Gait assessment (single)
The single walk will be evaluated with a 10-meter walking test and a G-Walk portable device.
Dual task gait assessment (motor+motor)
The dual task gait, 10-meter walking test and a motor (carrying a full water glass) will be combined with the task and evaluated with the G-Walk portable device.
Dual tak gait assessment (motor+cognitive)
The dual task gait will be combined with a 10-meter walking test and a cognitive (1-back test) task and evaluated with the G-Walk portable device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gait assessment (single)
The single walk will be evaluated with a 10-meter walking test and a G-Walk portable device.
Dual task gait assessment (motor+motor)
The dual task gait, 10-meter walking test and a motor (carrying a full water glass) will be combined with the task and evaluated with the G-Walk portable device.
Dual tak gait assessment (motor+cognitive)
The dual task gait will be combined with a 10-meter walking test and a cognitive (1-back test) task and evaluated with the G-Walk portable device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being in the age range of 6-18,
* To be physically, cognitively and mentally healthy,
* Open to communication enough to understand questions,
* Speaking and understanding Turkish,
* Approval has been obtained from the child and his / her family for the study and who agrees to participate in the study,
Case group:
* Able to walk alone without any walking aid,
* Open to communication enough to understand questions,
* Speaking and understanding Turkish,
* Approval has been obtained from the child and his / her family for the study and who agrees to participate in the study,
* Children between the ages of 6-18 will be included in the study
Exclusion Criteria
* Any orthopedic or neurological impairment that would prevent walking;
* Having any mental disability that prevents cognitive task
Case group:
* Staying in an isolated room or having risk of infection (neutropenic, etc.),
* Any orthopedic or neurological impairment that could prevent walking;
* Having any mental disability that prevents cognitive task,
* Individuals with malignant hypertension or unstable heart disease (eg congestive heart failure) will not be included in the study.
6 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Afyonkarahisar Health Sciences University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emel Taşvuran Horata
PhD; Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
EMEL TAŞVURAN HORATA, PhD
Role: PRINCIPAL_INVESTIGATOR
Afyonkarahisar Health Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emel Taşvuran Horata
Afyonkarahisar, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/144
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.